Sr Director, Executive Sales Lead, Central - TTR

This role is considered Virtual.

Overview

We are seeking a seasoned strategic commercial leader, with strong business acumen, launch experience and executive presence, who is passionate about people development and deeply motivated by the quest of delivering value to patients and their families.

The company is preparing for multiple commercial launches and is continuing to build U.S. and global commercial capabilities. Reporting to the VP, US TTR Sales, the successful candidate will be part of the U.S. sales leadership team responsible for the driving performance with AMVUTTRA® (vutrisiran) for the treatment of polyneuropathy of hATTR and preparing the sales organization for the potential launch and commercialization of AMVUTTRA in the second indication of cardiomyopathy of ATTR amyloidosis. Topline results for this study are expected to be available in late June or early July.  

The successful candidate will play a key role in the U.S. leading the sales organization to deliver against the AMVUTTRA territory, area and national goals. They will be responsible for TTR product commercialization through diligent talent selection, leadership and oversight of our field based TTR Regional Business Directors with appropriate coordination across Alnylam Assist® (our in-house Patient Support Services team), Field Reimbursement, Training, Business Operations, Legal and Compliance. They will partner closely with the U.S. Marketing team across all activities and coordinate appropriately with Medical Affairs. They will foster a culture of accountability and lead the sales team to meet or exceed targets. The achievement of objectives will be based on Alnylam values: our Commitment to People, Purposeful Urgency, Passion for Excellence, Open Culture, and Fiercely Innovative as well as our unwavering commitment to integrity.

Summary of Key Responsibilities

The Senior Director, Executive Sales Lead (Central), will support development of the field structure and customer facing strategies to deliver against the TTR Franchise goals with AMVUTTRA to treat the polyneuropathy of hATTR and prepare for the anticipated approval of the expanded indication in cardiomyopathy in ATTR, ensuring market leading and compliant coordination across Commercial, Medical Affairs and all additional supporting teams.

As a key member of the U.S. TTR Leadership Team, they will:

• Contribute to the future direction of the U.S. TTR Franchise supporting the strategic direction and development of in field executional plans in partnership with the core functional leads.
• Lead a team of approximately 5-6 Regional Business Directors (RBDs), tasked with building their teams and delivering patient and business value.
• Ensure team meets or exceeds targets following all compliance expectations.
• Develop a zone strategic plan to outline zone and regional objectives including competencies and capabilities.
• Lead the sales organization pre-launch and launch planning to support maximum uptake at approval.
• Provide input to design the incentive compensation plan in partnership with the East Executive Sales Lead and the VP, US TTR Sales and partner with the Field Operations team to establish the call plan, targets, expectations and tracking to effectively measure performance.
• Partner with Sales training leadership to develop coaching frameworks and capability to successfully engage in the field.
• Collaborate with IDN team, U.S. Marketing, Market Access, Patient Support Services, Business Operations, U.S. Medical Affairs, Legal, Compliance and other internal stakeholders to support the field with appropriate materials and programs; monitor progress and drive course correction where necessary.
• Establish appropriate U.S. targets and objectives, support definition of key performance indicators (KPIs) and proactively monitor and adjust incentives and metrics to drive success.
• Conduct field visits, regional and national team meetings to align teams, monitor execution, identify issues/opportunities and define new actions.
• Be deeply involved in the recruitment and onboarding of the Business Account Executives (BAEs) in conjunction with RBDs to hire and retain talent.

Qualifications and Key Competencies

• Seasoned commercial leader with 13+ years U.S. leadership experience in sales, marketing, commercial operations, and/or account management in commercial healthcare organizations.
• BA/BS Required
• MBA and/or other advanced scientific degree preferred (i.e., M.D., PhD or PharmD).
• Previous second line management and U.S. Specialty product Launch experience strongly preferred.
• Previous experience in additional functions beyond sales (marketing, market access, patient services) is strongly preferred
• Working knowledge of Buy/Bill and expertise of Part B & D preferred; knowledge of how to compliantly work with a case management and field reimbursement team required.
• Must be familiar with relevant legal and regulatory environment in biotech/pharmaceutical industry.
• Demonstrated leadership working in network operating model environment.
• Proven track record in driving culture of accountability.
• Effective planning, prioritization, management, and organizational skills.
• Ability to clearly communicate complex messages, accurately. To understand specific needs of intended audience and tailor communication accordingly, detail oriented with ability to understand big picture impact.
• Works collaboratively across expertise areas and functions; seeks to advance higher goals; highly regarded across stakeholders both at senior and junior levels; inspires trust at all levels; patient-centric, and passionate for innovation and discovery.
• Must be comfortable spending 50% of time traveling to visit customers, attend conferences and attend meetings in the Cambridge (MA) office.
• Candidate must have a valid U.S. driver’s license to be considered.
• Demonstrated commitment to ethics and integrity.
• Clear Alignment with Alnylam Core Values: Commitment to People, Purposeful Urgency, Passion for Excellence, Open Culture, and Fiercely Innovative

#LI-Remote

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.